ketotifen (Melbourne Laboratories)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Nameketotifen (Melbourne Laboratories)
Drug Alias Nameketotifen
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHistamine H1 receptor antagonists
TargetsHistamine H1 receptor
Therapy Area/IndicationsMastocytosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMelbourne Laboratories LLC
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMelbourne Laboratories LLC
Active IndicationsN/A
Inactive IndicationsMastocytosis

Other Information

ATC CodeN/A
Related LinksN/A